Skip to main content
Erschienen in: Acta Neurochirurgica 9/2014

01.09.2014 | Clinical Article - Vascular

Pathophysiology of flow impairment during carotid artery stenting with an embolus protection filter

verfasst von: Kentaro Hayashi, Nobutaka Horie, Minoru Morikawa, Susumu Yamaguchi, Shuji Fukuda, Yoichi Morofuji, Tsuyoshi Izumo, Izumi Nagata

Erschienen in: Acta Neurochirurgica | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

Carotid artery stenting (CAS) is a well-accepted treatment for atherosclerotic stenosis of carotid arteries. Since the occurrence of distal embolization with CAS is still a major concern embolus protection devices (EPD) are usually employed during the procedure. We examined two types of embolus protection filters (Angioguard XP (AG); Filterwire EZ (FW)) and evaluated the function. Thus, the filter was examined postoperatively and the cause of intraoperative flow impairment was evaluated.

Materials and methods

CAS was performed for 54 patients with carotid artery stenosis (55 lesions: 25 AG; 27 FW; 3 others). After completing CAS the filter membrane was stained with hematoxylin-eosin (HE) solution and removed from the filter strut. Once mounted on a glass slide the filter was evaluated under a microscope. The area occupied with debris was measured and the relationship to intraoperative flow impairment was evaluated. Furthermore, the relationship between perioperative ischemic complications and intraoperative flow impairment was statistically analyzed.

Results

Microscopic observation of the slide revealed the pore density of the FW was 1.5 times higher than that of the AG and the filter area of the FW was 2.5 times wider than than the AG. HE staining facilitated characterization of the debris composition. The area occupied with debris was significantly more in the AG (0.241 ±0.13 cm2) than in the FW (0.129 ±0.093 cm2). Thus, fibrin was significantly more precipitated in the AG. Flow impairment occurred in 6 AG cases (24.0 %) and 4 FW cases (14.8 %). It was induced by filter obstruction in the AG and by vasospasms in the FW. Three cases treated with AG (12.0 %) were complicated with cerebral infarction and all of them were related to flow impairment. One FW case (3.7 %) was complicated with cerebral infarction in presence of preserved flow throughout the intervention.

Conclusion

Filter function is different according to each design. The cause of flow impairment was attributable to filter obstruction in the AG group and to vasospasms in the FW group. Filter obstruction tends to result in cerebral infarction.
Literatur
1.
Zurück zum Zitat Angelini A, Reimers B, Della Barbera M, Saccà S, Pasquetto G, Cernetti C, Valente M, Pascotto P, Thiene G (2002) Cerebral protection during carotid artery stenting: collection and histopathologic analysis of embolized debris. Stroke 33:456–461PubMedCrossRef Angelini A, Reimers B, Della Barbera M, Saccà S, Pasquetto G, Cernetti C, Valente M, Pascotto P, Thiene G (2002) Cerebral protection during carotid artery stenting: collection and histopathologic analysis of embolized debris. Stroke 33:456–461PubMedCrossRef
2.
Zurück zum Zitat Casserly IP, Abou-Chebl A, Fathi RB, Lee DS, Saw J, Exaire JE, Kapadia SR, Bajzer CT, Yadav JS (2005) Slow-flow phenomenon during carotid artery intervention with embolic protection devices: predictors and clinical outcome. J Am Coll Cardiol 46:1466–1472PubMedCrossRef Casserly IP, Abou-Chebl A, Fathi RB, Lee DS, Saw J, Exaire JE, Kapadia SR, Bajzer CT, Yadav JS (2005) Slow-flow phenomenon during carotid artery intervention with embolic protection devices: predictors and clinical outcome. J Am Coll Cardiol 46:1466–1472PubMedCrossRef
3.
Zurück zum Zitat Hayashi K, Kitagawa N, Morikawa M (2005) Observing the carotid debris aspirated during carotid stenting: technical note. Neurol Res 27:22–26PubMedCrossRef Hayashi K, Kitagawa N, Morikawa M (2005) Observing the carotid debris aspirated during carotid stenting: technical note. Neurol Res 27:22–26PubMedCrossRef
4.
Zurück zum Zitat Hayashi K, Kitagawa N, Morikawa M, Hiu T, Morofuji Y, Suyama K, Nagata I (2009) Observation of the embolus protection filter for carotid artery stenting. Surg Neurol 72:532–537PubMedCrossRef Hayashi K, Kitagawa N, Morikawa M, Hiu T, Morofuji Y, Suyama K, Nagata I (2009) Observation of the embolus protection filter for carotid artery stenting. Surg Neurol 72:532–537PubMedCrossRef
5.
Zurück zum Zitat Honda M, Kitagawa N, Tsutsumi K, Nagata I, Morikawa M, Hayashi T (2006) High-resolution magnetic resonance imaging for detection of carotid plaques. Neurosurgery 58:338–346PubMedCrossRef Honda M, Kitagawa N, Tsutsumi K, Nagata I, Morikawa M, Hayashi T (2006) High-resolution magnetic resonance imaging for detection of carotid plaques. Neurosurgery 58:338–346PubMedCrossRef
6.
Zurück zum Zitat Horie N, Morikawa M, Ishizaka S, Takeshita T, So G, Hayashi K, Suyama K, Nagata I (2012) Assessment of carotid plaque stability based on the dynamic enhancement pattern in plaque components with multidetector CT angiography. Stroke 43:393–398PubMedCrossRef Horie N, Morikawa M, Ishizaka S, Takeshita T, So G, Hayashi K, Suyama K, Nagata I (2012) Assessment of carotid plaque stability based on the dynamic enhancement pattern in plaque components with multidetector CT angiography. Stroke 43:393–398PubMedCrossRef
7.
Zurück zum Zitat Iyer V, de Donato G, Deloose K, Peeters P, Castriota F, Cremonesi A, Setacci C, Bosiers M (2007) The type of embolic protection does not influence the outcome in carotid artery stenting. J Vasc Surg 46:251–256PubMedCrossRef Iyer V, de Donato G, Deloose K, Peeters P, Castriota F, Cremonesi A, Setacci C, Bosiers M (2007) The type of embolic protection does not influence the outcome in carotid artery stenting. J Vasc Surg 46:251–256PubMedCrossRef
8.
Zurück zum Zitat Kawahara I, Morikawa M, Nakamoto M, Kitagawa N, Tsutsumi K, Nagata I (2007) Evaluation of carotid artery plaque volume using high-resolution MRI. Jpn J Stroke 29:29–37CrossRef Kawahara I, Morikawa M, Nakamoto M, Kitagawa N, Tsutsumi K, Nagata I (2007) Evaluation of carotid artery plaque volume using high-resolution MRI. Jpn J Stroke 29:29–37CrossRef
9.
Zurück zum Zitat Kwon BJ, Han MH, Kang HS, Jung C (2006) Protection filter-related events in extracranial carotid artery stenting: a single-center experience. J Endovasc Ther 13:711–722PubMedCrossRef Kwon BJ, Han MH, Kang HS, Jung C (2006) Protection filter-related events in extracranial carotid artery stenting: a single-center experience. J Endovasc Ther 13:711–722PubMedCrossRef
10.
Zurück zum Zitat Kwon OK, Kim SH, Jacobsen EA, Marks MP (2012) Clinical implications of internal carotid artery flow impairment caused by filter occlusion during carotid artery stenting. AJNR Am J Neuroradiol 33:494–499PubMedCrossRef Kwon OK, Kim SH, Jacobsen EA, Marks MP (2012) Clinical implications of internal carotid artery flow impairment caused by filter occlusion during carotid artery stenting. AJNR Am J Neuroradiol 33:494–499PubMedCrossRef
11.
Zurück zum Zitat Loghmanpour NA, Siewiorek GM, Wanamaker KM, Muluk SC, Chaer R, Wholey MH, Finol EA (2013) Assessing the impact of distal protection filter design characteristics on 30-day outcomes of carotid artery stenting procedures. J Vasc Surg 57:309–317PubMedCrossRef Loghmanpour NA, Siewiorek GM, Wanamaker KM, Muluk SC, Chaer R, Wholey MH, Finol EA (2013) Assessing the impact of distal protection filter design characteristics on 30-day outcomes of carotid artery stenting procedures. J Vasc Surg 57:309–317PubMedCrossRef
12.
Zurück zum Zitat Maleux G, Demaerel P, Verbeken E, Daenens K, Heye S, Van Sonhoven F, Nevelsteen A, Wilms G (2006) Cerebral ischemia after filter-protected carotid artery stenting is common and cannot be predicted by the presence of substantial amount of debris captured by the filter device. AJNR Am J Neuroradiol 27:1830–1833PubMed Maleux G, Demaerel P, Verbeken E, Daenens K, Heye S, Van Sonhoven F, Nevelsteen A, Wilms G (2006) Cerebral ischemia after filter-protected carotid artery stenting is common and cannot be predicted by the presence of substantial amount of debris captured by the filter device. AJNR Am J Neuroradiol 27:1830–1833PubMed
13.
Zurück zum Zitat Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X, EVA-3S Investigators (2006) Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355:1660–1671PubMedCrossRef Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X, EVA-3S Investigators (2006) Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355:1660–1671PubMedCrossRef
14.
Zurück zum Zitat Powell RJ, Alessi C, Nolan B, Rzucidlo E, Fillinger M, Walsh D, Wyers M, Zwolak R, Cronenwett JL (2006) Comparison of embolization protection device-specific technical difficulties during carotid artery stenting. J Vasc Surg 44:56–61PubMedCrossRef Powell RJ, Alessi C, Nolan B, Rzucidlo E, Fillinger M, Walsh D, Wyers M, Zwolak R, Cronenwett JL (2006) Comparison of embolization protection device-specific technical difficulties during carotid artery stenting. J Vasc Surg 44:56–61PubMedCrossRef
15.
Zurück zum Zitat Roffi M, Greutmann M, Schwarz U, Luscher TF, Eberli FR, Amann-Vesti B (2008) Flow impairment during protected carotid artery stenting: impact of filter device design. J Endovasc Ther 15:103–109PubMedCrossRef Roffi M, Greutmann M, Schwarz U, Luscher TF, Eberli FR, Amann-Vesti B (2008) Flow impairment during protected carotid artery stenting: impact of filter device design. J Endovasc Ther 15:103–109PubMedCrossRef
17.
Zurück zum Zitat Sakamoto M, Taoka T, Nakagawa H, Takayama K, Wada T, Myouchin K, Akashi T, Miyasaka T, Fukusumi A, Iwasaki S, Kichikawa K (2010) Magnetic resonance plaque imaging to predict the occurrence of the slow-flow phenomenon in carotid artery stenting procedures. Neuroradiology 52:275–283PubMedCrossRef Sakamoto M, Taoka T, Nakagawa H, Takayama K, Wada T, Myouchin K, Akashi T, Miyasaka T, Fukusumi A, Iwasaki S, Kichikawa K (2010) Magnetic resonance plaque imaging to predict the occurrence of the slow-flow phenomenon in carotid artery stenting procedures. Neuroradiology 52:275–283PubMedCrossRef
18.
Zurück zum Zitat Schönholz CJ, Uflacker R, Mendaro E, Parodi JC, Guimaraes M, Hannegan C, Selby B (2005) Techniques for carotid artery stenting under cerebral protection. J Cardiovasc Surg 46:201–217 Schönholz CJ, Uflacker R, Mendaro E, Parodi JC, Guimaraes M, Hannegan C, Selby B (2005) Techniques for carotid artery stenting under cerebral protection. J Cardiovasc Surg 46:201–217
19.
Zurück zum Zitat Ringleb PA, Allenberg J, Brückmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W, SPACE Collaborative Group (2006) 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368:1239–1247PubMedCrossRef Ringleb PA, Allenberg J, Brückmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W, SPACE Collaborative Group (2006) 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368:1239–1247PubMedCrossRef
20.
Zurück zum Zitat Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K (2004) Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493–1501PubMedCrossRef Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K (2004) Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493–1501PubMedCrossRef
Metadaten
Titel
Pathophysiology of flow impairment during carotid artery stenting with an embolus protection filter
verfasst von
Kentaro Hayashi
Nobutaka Horie
Minoru Morikawa
Susumu Yamaguchi
Shuji Fukuda
Yoichi Morofuji
Tsuyoshi Izumo
Izumi Nagata
Publikationsdatum
01.09.2014
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 9/2014
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-014-2180-z

Weitere Artikel der Ausgabe 9/2014

Acta Neurochirurgica 9/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.